UltraGlycemX (Original Flavour)
Natural health product licensed in Canada
- Licence holder
- Metagenics Inc.
- NPN or DIN-HM
- 80050548
- Status
- Inactive licence
- Licence date
- 1 May 2014
- Revision date
- Not provided
- Form
- Poudre
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Cuivre | 500 microgrammes | Not calculated |
| Potassium | 227.5 mg | Not calculated |
| Riboflavine | 0.5 mg | Not calculated |
| Bêta-carotène | 750 microgrammes | Not calculated |
| Phosphore | 220 mg | Not calculated |
| Zinc | 6.5 mg | Not calculated |
| Biotine | 2,500 microgrammes | Not calculated |
| Magnésium | 110 mg | Not calculated |
| Chrome | 250 microgrammes | Not calculated |
Non-medicinal ingredients
Saveur de chocolat, Maltodextrine, Saveur de vanille, Saveur, D-Fructose, Saveur de guimauve
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 2 Mesures | 1 day |
Uses authorised in Canada
Provides support for healthy glucose metabolism. Provide antioxidants. Multi-Vitamin/Mineral Supplement. Potassium supplement for the maintenance of good health. Helps the body to metabolize carbohydrates, fats and proteins. Helps normal growth and development.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
If you are breastfeeding, consult a healthcare practitioner before use. Consult a healthcare practitioner prior to use if you are taking thyroid hormone replacement therapy. Consult a healthcare practitioner prior to use if you have a liver disorder or develop liver-related symptoms (e.g. abdominal pain, jaundice, dark urine). May cause nausea, vomiting, diarrhea, abdominal cramps; discontinue use and consult a health care practitioner if these symptoms are severe. People sensitive to nicotinic acid may experience flushing of the skin that is generally mild and transient.
Source
Official Health Canada record, licence 80050548
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.